Article in The Lancet provides safety and efficacy data from phase 3 trial of ROTAVAC®

A second study by World Health Organization suggests keeping vaccines at ambient temperatures during campaigns could cut storage and transportation costs in half

PATH receives two Grand Challenges Explorations grants to advance a new class of cold chain equipment and simplify human milk banking systems

Ashley Birkett, PhD, to lead key product development program at PATH

Milestone marks the first prequalified JE vaccine for children and the first Chinese vaccine manufacturer to achieve prequalification

Breakthrough health innovations could save 1.2 million mothers and children by the end of 2015

Study in The Lancet shows remarkable effectiveness of vaccine developed through a PATH-WHO partnership

International conference showcases recent innovations in skin-mediated vaccination advanced by PATH and partners

PATH will lead five-year, multi-million dollar initiative aimed at creating transformative impact to increase immunization coverage

Partners announce positive phase 3 clinical trial results for affordable rotavirus vaccine

Dose-reduction strategies could help conserve 420 million doses of yellow fever vaccine by 2022, new report concludes

Supplement from the journal Vaccine explores opportunities and challenges of the Global Vaccine Action Plan

Document provides ambitious framework for expanding vaccine access

New video highlights importance of strengthening vaccine supply and logistics systems

Trio recognized for advancing vaccines for low-resource settings

Advocacy efforts led by PATH help safeguard access to vaccines in treaty limiting mercury in the environment

Follow-on agreement will lead to clinical trials

Longtime PATH leader honored by Vietnam’s Ministry of Health

Affordable, safe, effective vaccine protecting young people from devastating disease

Innovation helps to ensure vaccine performance and effectiveness outside of the cold chain

New flexibility to help expand access to MenAfriVac®, as Benin prepares to roll out vaccine that scientists say is having dramatic impact on disease

Results from ongoing Phase III clinical trial announced

Malawi becomes the 10th GAVI-supported country to introduce vaccines against most common cause of severe and fatal diarrhoea

Decade of Vaccines Collaboration leadership pledges support for universal access to immunization

PATH receives two Grand Challenges Explorations grants to explore new ways to deliver and manage vaccine supplies

Dr. F. Marc LaForce of the Meningitis Vaccine Project recognized with 2012 Albert B. Sabin Gold Medal Award

Meningitis Vaccine Project recognized for collaboration that produced new meningitis A vaccine

Special supplemental issue of the journal Vaccine provides critical insights on rotavirus vaccine performance to help maximize their impact in developing countries

Gates Foundation seeks bold new ideas to optimize immunization systems

African pediatricians urge leaders to make vaccines a priority

Congressional hearing highlights progress against malaria and challenges that remain